WEST CHESTER, Ohio--(BUSINESS WIRE)--Jan 31, 2013--AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems for the treatment of atrial fibrillation, or AF, and systems for the exclusion of the left atrial appendage, today announced that it will present at the Leerink Swann 2013 Global Healthcare Conference at the Waldorf Astoria Hotel in New York on Thursday, February 14, 2013. Management is scheduled to present at 2:30 p.m. Eastern Time.
A live audio webcast and replay of the presentation will be available for 30 days following the presentation at www.atricure.com.
About AtriCure, Inc. AtriCure, Inc. is a medical device company and a leader in developing, manufacturing and selling innovative cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac, or heart, tissue for the treatment of atrial fibrillation, or AF, and systems for the exclusion of the left atrial appendage. For more information, please visit www.atricure.com.CONTACT: AtriCure, Inc.
Andy Wade, 513-755-4564 Vice President and Chief Financial Officer email@example.com or Investor Relations Contact: Westwicke Partners Lynn Pieper, 415-202-5678 Lynn.firstname.lastname@example.org KEYWORD: UNITED STATES NORTH AMERICA NEW YORK OHIO INDUSTRY KEYWORD: SURGERY HEALTH CARDIOLOGY HOSPITALS MEDICAL DEVICES FDA SOURCE: AtriCure, Inc. Copyright Business Wire 2013 PUB: 01/31/2013 05:30 PM/DISC: 01/31/2013 05:30 PM http://www.businesswire.com/news/home/20130131006719/